Cite
HARVARD Citation
Rendas-Baum, R. et al. (2014). FRI0178 Estimated Medical Expenditures among Patients with Rheumatoid Arthritis Undergoing Treatment with Tofacitinib, an Oral Janus Kinase Inhibitor. Annals of the rheumatic diseases. p. 446. [Online].